Skip to main content
. 2019 Sep 26;31(2):e19. doi: 10.3802/jgo.2020.31.e19

Fig. 4. Clinical outcome. (A-C) Patients with UCAA biopsied post-12Gy-C, with positive (blue, n=22) or negative (orange, n=11) PD-L1. (D-F) PD-L1/lymphocyte status and clinical outcome. Groups A (n=8), B (n=14), C (n=4), and D (n=7). (A, D) LC. (B, E) PFS. (C, F) OS.

Fig. 4

CIRT, carbon-ion radiotherapy; LC, local control; OS, overall survival; PD-L1, programmed cell death-ligand 1; PFS, progression-free survival; UCAA, uterine cervical adeno/adenosquamous carcinoma.